The global pandemic alert for coronavirus illness (COVID-19) is a huge problem, and numerous attempts have been made to prevent and control the epidemic. Many effective vaccinations have recently been found, and they have shown to provide significant protection against infection.
Coronavirus Disease Infection after Vaccination among Type 2 Diabetes Mellitus Patients
Despite the fact that COVID-19 vaccinations are effective and are being used to control/halt the pandemic’s progress, no vaccine can totally prevent the infection. Even completely vaccinated persons can become ill, and some may need to be hospitalised or die as a result of COVID-19.
Evidence suggests that vaccination may reduce the severity of the illness, lowering the risk of infection, hospitalisation, and mortality in vaccinated people compared to non-vaccinated people. The goal of this study was to see if type 2 diabetes mellitus (T2DM) patients in a tertiary care hospital developed COVID-19 infection following vaccination.
After obtaining their immunisation, 22 trained nurses were infected with COVID-19, according to a recent study. In addition, the infection might be discovered at any time after the second vaccine dose was administered, and two-thirds of the breakthrough infections were silent.
As a result, minimising vaccine failures owing to variations is an important element of pandemic management. It’s critical to understand how variations might evade vaccine-induced immunity and create asymptomatic infection (which can lead to viral spread) or sickness, which must be addressed separately.